Cosmos Holdings, Inc., through its wholly owned subsidiary Sky Pharm S.A., offers a first look at its Sky Life Premium® Brand of food supplements.
CHICAGO, IL- - April 19, 2018 - Cosmos Holdings, Inc. (OTCQB: COSM), released the design and packaging of its first set of dietary supplements. These premium supplements boast a sleek design and packaging along with best in class formulation. The first lines of products include: A herbal syrups with natural ingredients from Greece, Collagen 24k, Organic Aloe Vera, Hyaluronic, Male & Female Multivitamins, Q10 Coenzyme, DNA repair supplement, Hair supplement for stronger & shinier hair, and Turmeric.
Cosmos Holdings CEO Gregory Siokas commented, “This marks the completion of yet another milestone for Cosmos Holdings Inc. We are gearing up and are excited to release our product line to the European market in the coming months. The excitement is also shared by our wholesale partners as we get ready to ramp up production.”
Cosmos Holdings, Inc. takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release or the information contained herein by any third-parties, including, but not limited to, any wire or internet services.
FORWARD LOOKING STATEMENTS
Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Important factors that might cause such differences are discussed in the Company's filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated in these forward-looking statements, if new information becomes available in the future.